John Lin, MD is a Fellow in Hematology/Oncology at the University of Pennsylvania. His research interests are in evaluating the value of novel and high-cost oncology therapies (such as CAR-T) as well as assessing the impact of payment policies on patients who have cancer. John completed a health services research fellowship at Stanford University (2019). He received an AB from Harvard University (2008) in Economics and Healthcare Policy, an MD from Baylor College of Medicine (2014), and completed his Internal Medicine residency at the University of California San Francisco (2017).
John Lin, MD
- Fellow, Hematology/Oncology, Perelman School of Medicine